<--- Back to Details
First PageDocument Content
Pharmaceuticals policy / Dornase alfa / Medical prescription / Mannitol / Pharmaceutical Benefits Scheme / Cystic fibrosis / Pharmacy / Pharmacist / Benzofuranylpropylaminopentane / Health / Medicine / Pharmacology
Date: 2014-01-13 00:33:02
Pharmaceuticals policy
Dornase alfa
Medical prescription
Mannitol
Pharmaceutical Benefits Scheme
Cystic fibrosis
Pharmacy
Pharmacist
Benzofuranylpropylaminopentane
Health
Medicine
Pharmacology

Add to Reading List

Source URL: www.cysticfibrosis.org.au

Download Document from Source Website

File Size: 539,15 KB

Share Document on Facebook

Similar Documents

Cystic Fibrosis Physical Therapist Mentoring Program: Information Sheet Purpose The purpose of the CF Physical Therapist Mentoring Program is to provide resources and information for physical therapists that are new to C

DocID: 1vlMn - View Document

INTRODUCTION A GUIDE FOR PARENTS OF NEWLY DIAGNOSED CHILDREN WITH CYSTIC FIBROSIS This booklet has been written to help you get a better understanding of Cystic (CF) Fibrosis. It is not intended to replace any advice yo

DocID: 1vjMY - View Document

WHY ANTIBIOTICS ARE IMPORTANT FOR... CYSTIC FIBROSIS PATIENTS People with cystic fibrosis (CF) are more likely to get chest infections. These can lead to complications and even death, so antibiotics are an essential par

DocID: 1viVM - View Document

Genetic Carrier Testing For Cystic Fibrosis Published by the Cystic Fibrosis Association of Ireland

DocID: 1vb5J - View Document

Cystic fibrosis Key facts • Cystic fibrosis (CF) is an inherited condition of the exocrine glands, most commonly presenting during

DocID: 1v1tb - View Document